Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
Explore this paper's citation graph
Summary
The present article reviews the pharmacokinetic properties of vancomycin, linezolid, tigecycline and daptomycin and examines their oral bioavailability, elimination pathways, and half-life.
- Type
- article
- Published
- 2010-11-30
- Cited by
- 76
- References
- 78
- Access
- Open access
- OpenAlex
- https://openalex.org/W1964646227
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:16054542
Keywords
Tigecycline, Daptomycin, Linezolid, Vancomycin, Pharmacokinetics
References
- In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
- First Report of cfr-Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States
- Pharmacological Issues of Linezolid
- Drug diffusion and bioavailability: tetracycline metallic chelation.
- Effects of cigarette smoke on salivary protein tyrosine nitration
- MRSA--the tip of the iceberg.
- The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology
- Update on the appropriate use of linezolid in clinical practice
- Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections
- Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers
- Pharmacokinetics of Unbound Linezolid in Plasma and Tissue Interstitium of Critically Ill Patients after Multiple Dosing Using Microdialysis
- In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004).
- Effects of Age and Sex on Single-Dose Pharmacokinetics of Tigecycline in Healthy Subjects
- Risk Factors for Treatment Failure in Patients Receiving Vancomycin for Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Pneumonia
- Pharmacodynamics of Tigecycline against Phenotypically Diverse Staphylococcus aureus Isolates in a Murine Thigh Model
- Pharmacokinetics and dialysate levels of daptomycin given intravenously in a peritoneal dialysis patient
- Antibacterial Dosing in Intensive Care
- Single-Dose Pharmacokinetics of Daptomycin in Children With Suspected or Proved Gram-Positive Infections
- The Pharmacokinetics of Daptomycin in Moderately Obese, Morbidly Obese, and Matched Nonobese Subjects
- Single‐Dose Pharmacokinetics of Daptomycin in Young and Geriatric Volunteers
Cited by
- Inhibition of Panton-Valentine Leukocidin Toxin Induced Neutrophil Cell Lysis by Vancoplus in Methicillin-Resistant Staphylococcus Aureus Infections
- Daptomycin: Physicochemical, Analytical, and Pharmacological Properties
- PREVALENCE OF HETEROGENEOUS GLYCOPEPTIDE INTERMEDIATE RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
- Linezolid Has Unique Immunomodulatory Effects in Post-Influenza Community Acquired MRSA Pneumonia
- Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
- Frequency of Susceptibility Testing for Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
- Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections.
- In vitro susceptibility of Campylobacter jejuni from Kuwait to tigecycline & other antimicrobial agents
- Tigecycline pharmacokinetics, tolerability, safety, and effect on intestinal microflora in healthy Japanese male subjects
- Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.
- Anti-Alpha-Toxin Monoclonal Antibody and Antibiotic Combination Therapy Improves Disease Outcome and Accelerates Healing in a Staphylococcus aureus Dermonecrosis Model
- A Rationale for Maintaining Current Tigecycline Breakpoints as Established by the USA Food and Drug Administration
- Safety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review
- A Review on Daptomycin; the first US-FDA approved Lipopeptide antibiotics
- Évaluation des prescriptions de linézolide dans 3 centres hospitaliers de la région Rhône-Alpes
- A Physiologically-Based Pharmacokinetic Model for Vancomycin
- Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease
- Pulmonary delivery of vancomycin dry powder aerosol to intubated rabbits
- Determination of Susceptibility to Tigecycline in Extended Spectrum Beta-laktamase Producing Escherichia coli Isolates
- Biological profiling of novel tricyclic inhibitors of bacterial DNA gyrase and topoisomerase IV.
Related papers
- Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycin.
- Комбинированная терапия как путь к предотвращению антибиотикорезистентности бактерий: линезолид-даптомицин против Staphylococcus aureus
- Evaluation of the antimicrobial activity of daptomycin and linezolid against vancomycin-resistant Enterococcus spp. isolates in south India.
- Activity of vancomycin, linezolid, and daptomycin against staphylococci and enterococci isolated in 5 Greek hospitals during a 5-year period (2008-2012).
- Comparison of Linezolid and Daptomycin in the Treatment of Vancomycin-Resistant Enterococcal Bacteremia
- Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm.
- In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin-Resistant Staphylococcus aureus Isolates Collected from Chinese Hospitals in 2018–2020
- Evaluation of the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis.
- Differential susceptibility of staphylococcus epidermidis biofilms to vancomycin, daptomycin and linezolid between clinical isolates from neonates and adults